PyrazolopyrimidineZNL0325,Kinases

Zhengnian Li1, Wenchao Lu2, Tyler S Beyett3,4

  • 1Department of Chemical and Systems Biology, Chem-H and Stanford Cancer Institute, Stanford School of Medicine, Stanford University, Stanford, California 94305, United States.

PubMed
概括

我们发现了ZNL0325,一种新型的pyrazolopyrimidine激酶抑制剂. 它以独特的翻转模式结合激酶,使共价抑制成为可能,并提供新的药物设计策略.